Evidence map›Paper›PMID 33401739›Full record

ReviewSensors (Basel, Switzerland)2021

Optical Technologies for the Improvement of Skin Cancer Diagnosis: A Review.

Laura Rey-Barroso, Sara Peña-Gutiérrez, Carlos Yáñez, Francisco J Burgos-Fernández, Meritxell Vilaseca, Santiago Royo

Open access · goldAbstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura Rey-BarrosoCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.
Sara Peña-GutiérrezCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.
Carlos YáñezCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.
Francisco J Burgos-FernándezCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.ORCID 0000-0002-3749-6850
Meritxell VilasecaCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.ORCID 0000-0001-8166-1617
Santiago RoyoCentre for Sensors, Instruments and Systems Development, Universitat Politècnica de Catalunya, 08222 Terrassa, Spain.ORCID 0000-0003-0136-8301
Universitat Politècnica de Catalunya · ES

Funding

European Regional Development Fund (FEDER) FIS2017-89850-R.Ministerio de Economía, Industria y Competitividad (MINECO), Agencia Estatal de Investigación (AEI) DPI2017-89414-R
6 · The paper itself

Abstract

The worldwide incidence of skin cancer has risen rapidly in the last decades, becoming one in three cancers nowadays. Currently, a person has a 4% chance of developing melanoma, the most aggressive form of skin cancer, which causes the greatest number of deaths. In the context of increasing incidence and mortality, skin cancer bears a heavy health and economic burden. Nevertheless, the 5-year survival rate for people with skin cancer significantly improves if the disease is detected and treated early. Accordingly, large research efforts have been devoted to achieve early detection and better understanding of the disease, with the aim of reversing the progressive trend of rising incidence and mortality, especially regarding melanoma. This paper reviews a variety of the optical modalities that have been used in the last years in order to improve non-invasive diagnosis of skin cancer, including confocal microscopy, multispectral imaging, three-dimensional topography, optical coherence tomography, polarimetry, self-mixing interferometry, and machine learning algorithms. The basics of each of these technologies together with the most relevant achievements obtained are described, as well as some of the obstacles still to be resolved and milestones to be met.

Indexed as

MelanomaSkin NeoplasmsHumansMicroscopy, ConfocalTomography, Optical Coherence3D topographyconfocal microscopymachine learningmelanomamultispectral imagingoptical coherence tomographyoptical feed-back interferometrypolarimetryskin cancer

Identifiers

PMID33401739
PMCPMC7795742
OpenAlexW3120891898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.